Kolon Life Science Inc - Asset Resilience Ratio

Latest as of March 2025: 1.22%

Kolon Life Science Inc (102940) has an Asset Resilience Ratio of 1.22% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩7.33 Billion

≈ $4.97 Million USD Cash + Short-term Investments

Total Assets

₩601.96 Billion

≈ $407.94 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Kolon Life Science Inc's Asset Resilience Ratio has changed over time. Check Kolon Life Science Inc (102940) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Kolon Life Science Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Kolon Life Science Inc stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩7.33 Billion	1.22%
Short-term Investments	₩0.00	0%
Total Liquid Assets	₩7.33 Billion	1.22%

Asset Resilience Insights

Limited Liquidity: Kolon Life Science Inc maintains only 1.22% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Kolon Life Science Inc Industry Peers by Asset Resilience Ratio

Compare Kolon Life Science Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Theragen Etex Co.Ltd KQ:066700	Pharmaceuticals	0.68%
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Oscotec Inc KQ:039200	Pharmaceuticals	65.38%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Komipharm International Co. Ltd KQ:041960	Pharmaceuticals	0.00%

Annual Asset Resilience Ratio for Kolon Life Science Inc (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Kolon Life Science Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.96%	₩12.42 Billion ≈ $8.41 Million	₩419.56 Billion ≈ $284.33 Million	+0.54pp
2023-12-31	2.42%	₩7.48 Billion ≈ $5.07 Million	₩309.44 Billion ≈ $209.70 Million	+0.39pp
2022-12-31	2.03%	₩6.37 Billion ≈ $4.32 Million	₩314.12 Billion ≈ $212.87 Million	-9.87pp
2021-12-31	11.89%	₩27.91 Billion ≈ $18.91 Million	₩234.66 Billion ≈ $159.02 Million	+5.84pp
2020-12-31	6.05%	₩15.03 Billion ≈ $10.19 Million	₩248.34 Billion ≈ $168.29 Million	-1.46pp
2019-12-31	7.51%	₩20.91 Billion ≈ $14.17 Million	₩278.29 Billion ≈ $188.60 Million	+1.41pp
2018-12-31	6.10%	₩37.77 Billion ≈ $25.60 Million	₩618.90 Billion ≈ $419.42 Million	-4.89pp
2017-12-31	11.00%	₩78.83 Billion ≈ $53.42 Million	₩716.80 Billion ≈ $485.76 Million	-27.88pp
2016-12-31	38.88%	₩137.85 Billion ≈ $93.42 Million	₩354.57 Billion ≈ $240.29 Million	--

pp = percentage points

About Kolon Life Science Inc

KQ:102940 Korea Pharmaceuticals

Market Cap

$232.71 Million

₩343.39 Billion KRW

Market Cap Rank

#15895 Global

#537 in Korea

Share Price

₩30100.00

Change (1 day)

-6.67%

52-Week Range

₩28400.00 - ₩70800.00

All Time High

₩163572.85